ForianFORA 46 Buyback Yield % is 0.00 as of Jun. 26, 2026. GuruFocus rates FORA with a GF Score™ of 46/100 and a GF Value™ of $3.25 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 271 Healthcare Providers & Services companies, Forian ranks worse than 369003.32% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Forian's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FORA vs DRIO, ONMD, BEAT: Buyback Yield % Comparison
For the Health Information Services subindustry, Forian's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Forian Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Forian's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Forian's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Forian (FORA) has a Buyback Yield % of 0.00 as of Jun. 26, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Forian and its competitors. According to the industry distribution chart, Forian ranks #999999 out of 271 companies in the Healthcare Providers & Services industry.
Is Forian's Buyback Yield % too high?
Forian's current Buyback Yield % is 0.00. Based on the distribution chart, Forian ranks #999999 out of 271 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Forian has a GF Score™ of 46/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Forian's Buyback Yield % compare to DRIO and ONMD?
According to the Healthcare Providers & Services industry distribution chart, Forian ranks #999999 out of 271 companies for Buyback Yield %. This places Forian in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Forian and its competitors. Forian's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Forian stock overvalued right now?
Based on GuruFocus' analysis, Forian (FORA) is currently considered Significantly Undervalued. The stock's GF Value™ is $3.25, compared to a current price of $2.17 — trading 33.2% below its estimated fair value. The current Buyback Yield % is 0.00. Forian's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Forian (FORA), the current Buyback Yield % is 0.00 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Forian (FORA) Overvalued in 2026?
Based on GuruFocus' analysis, Forian stock appears to be undervalued.
The current stock price of $2.17 is trading 33.2% below its estimated GF Value™ of $3.25.
GuruFocus considers Forian to be Significantly Undervalued.
Key valuation signals for FORA:
Buyback Yield %: 0.00
GF Value™: $3.25 vs. price of $2.17 (33.2% below fair value)
No single metric tells the full story. See the FORA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.
46GF Score
Get the complete analysis for FORA
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FORA has been successfully added to your 
